LifeCell (US) gets closer to off-the-shelf skin:
This article was originally published in Clinica
Executive Summary
LifeCell (US) has moved closer to its goal of an off-the-shelf, full-thickness skin graft following the first animal study of cultured keratinocytes on its AlloDerm dermal graft. The company grafted a composite skin comprising AlloDerm and cultured neonatal foreskin keratinocytes onto full-thickness wounds on mice. The study showed that the human keratinocytes grew in immunocompromised mice only when co-cultured onto AlloDerm prior to grafting, according to the company.